According to reports based on local authorities in the Indian media, Pfizer made an application to the Indian General Drug Inspectorate (DCGI) the previous day, requesting approval for the vaccine candidate Kovid-19 “BNT162b2” developed with the German biotech company BioNTech to be shipped to the country for sale and distribution.
In India, where advanced clinical trials of 5 vaccines are currently underway, this is the first time that a pharmaceutical company has applied for emergency use of the Covid-19 vaccine.
In the country, the third stage clinical trials of the domestic vaccine candidate developed by the Indian biotech company Bharat Biotech against Covid-19 began on November 27th.
England, Turkish scientist Prof. Dr. The German biotechnology company BioNTech, of which Uğur Şahin is a founding partner, approved the widespread use of the Covid-19 vaccine developed with the American pharmaceutical company Pfizer on Wednesday.
140 thousand 216 people died due to Covid-19 detected in 9 million 644 thousand 529 people in India.